2021年度

＜著書＞

1. 上田順宏，桐田忠昭：フェイスガード；要説 スポーツ歯科医学．第2版，医学情報社，東京，2021，121-124頁．

2. 山川延宏，桐田忠昭：口腔がんの手術法；口腔外科ハンドマニュアル’21．クインテッセンス出版株式会社，東京，2021，98-107頁．

 

＜一般論文＞（欧文）

1. Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer.
Ueda N, Aoki K, Shimotsuji H, Nakashima C, Kawakami M, Imai Y, Kirita T.
J Bone Miner Metab. 39:623-630, 2021.

2. Risk factors for post-extraction bleeding in patients with haemophilia: a retrospective cohort study.
Yagyuu T, Yata S, Imada M, Funayama N, Imai Y, Yada K, Nogami K, Kirita T.
Br J Oral Maxillofac Surg. 59(3):341-346, 2021.

3. Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study.
Yagyuu T, Funayama N, Imada M, Kirita T.
PLoS One. 16(4): doi:10.1371/journal.pone.0250359. eCollection 2021.

4. Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.
Hasegawa T, Ueda N, Yamada S, Kato S, Iwata E, Hayashida S, Kojima Y, Shinohara M, Tojo I, Nakahara H, Yamaguchi T, Kirita T, Kurita H, Shibuya Y, Soutome S, Akashi M, Japanese Study Group of Co-operative Dentistry with Medicine(JCDM).
Osteoporos Int. 32(11):2323-2333, 2021.

5. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.
Kishi S, Nishiguchi Y, Honoki K, Mori S, Fujiwara-Tani R, Sasaki T, Fujii K, Kawahara I, Goto K, Nakashima C, Kido A, Tanaka Y, Luo Y, Kuniyasu H.
Int J Mol Sci. 22(10):5185, 2021.

6. Enhancement of Anti-Tumoral Immunity by β-Casomorphin-7 Inhibits Cancer Development and Metastasis of Colorectal Cancer.
Mori S, Fujiwara-Tani R, Kishi S, Sasaki T, Ohmori H, Goto K, Nakashima C, Nishiguchi Y, Kawahara I, Luo Y, Kuniyasu H.
Int J Mol Sci. 22(15):8232, 2021.

7. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
Ueda N, Nakashima C, Aoki K, Shimotsuji H, Nakaue K, Yoshioka H, Kurokawa S,Imai Y, Kirita T.
Clin Oral Investig. 25(5):3087-3093, 2021.

8. Multicenter retrospective study of weekly cetuximab plus paclitaxel for recurrent or metastatic oral squamous cell carcinoma.
Naruse T, Yanamoto S, Otsuru M, Yamakawa N, Kirita T, Shintani Y, Matsumura T, Okura M, Sasaki M, Ota Y, Yamada S, Kurita H, Umeda M, Japan OralOncology Group(JOOG).
Anticancer Research. 41(11):5785-5791, 2021.

9. A Case of Synovial Chondromatosis of Temporomandibular Joint with Numerous Loose Bodies.
Matsusue Y, Yamamoto K, Yamakawa N, Yamamoto I, Matsuda S, Yoshimura H, Kawakami T, Kirita T.
Case Rep Dent. doi:10.1155/2021/5927215. eCollection 2021.

10. BRAF Mutation Is Associated with Hyperplastic Polyp-Associated Gastric Cancer.
Fujiwara-Tani R, Okamoto A, Katsuragawa H, Ohmori H, Fujii K, Mori S, Kishi S, Sasaki T, Nakashima C, Kawahara I, Hojo Y, Nishiguchi Y, Mori T,Mizumoto T, Nagai K, Luo Y, Kuniyasu H.
Int J Mol Sci. 22(23):12724, 2021.

11. Analysis of implant stability changes in immediate loading using a laser displacement sensor in vivo and comparison of its sensitivity with that of resonance frequency analysis.
Murakami K, Yamamoto K, Ishida J, Tsutsumi S, Kirita T.
Clin Oral Implants Res. 32(11):1341-1356, 2021.

12. SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis.
Sasahira T, Kurihara-Shimomura M, Shimomura H, Kirita T.
Int J Clin Oncol. 26(10):1831-1839, 2021.

13. General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis.
Ota Y, Noguchi T, Ariji E, Fushimi C, Fuwa N, Harada H, Hayashi T, Hayashi R, Honma Y, Miura M, Mori T, Nagatsuka H, Okura M, Ueda M, Uzawa N, Yagihara K, Yagishita H, Yamashiro M, Yanamoto S, Kirita T; Scientific Committee on General
Rules for Clinical and Pathological Studies of Oral Cancer, Japanese Society of Oral Oncology.
Int J Clin Oncol. 26(4):623-635, 2021.

14. Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.
Sasahira T, Kurihara-Shimomura M, Shimomura H, Bosserhoff AK, Kirita T.
J Cancer Res Clin Oncol. 147(6):1659-1672, 2021.

15. Preoperative underweight is associated with adverse postoperative events in patients undergoing microvascular reconstruction surgery for oral and maxillofacial cancer.
Shida A, Ida M, Ueda M, Kirita T, Kawaguchi M.
Int J Oral Maxillofac Surg. 50(5):598-603, 2021.

 

＜一般論文＞（和文）

1. 血清CEAとCA19-9異常高値にて発見された臼後部に生じたIntraductal carcinomaの1例
河上真緒，上田順宏，髙橋佑佳，有川　翔，山川延宏，桐田忠昭
日本口腔外科学会雑誌．67(5)：292-296，2021．

2. 先天性第Ⅴ因子欠乏症患者に対して両側上顎智歯抜歯を行った1例
髙橋佑佳，柳生貴裕，山川延宏，上田順宏，桐田忠昭
日本口腔科学会雑誌．70(1)：39-42，2021．

3. 睡眠時無呼吸症において口腔内装置(OA)治療で生じる顎関節症症状とその対応
川上哲司，桐田忠昭
睡眠口腔医学．7(3)：96-101，2021．

4. 中耳炎を契機に発症した急性化膿性顎関節炎から硬膜外膿瘍をきたした1例
髙橋佑佳，上田順宏，川上哲司，松末友美子，仲川洋介，桐田忠昭
日本口腔外科学会雑誌．67(10)：601-605，2021．

5. 下顎歯肉癌切除後の歯科インプラントによる咀嚼機能回復 -口腔外科の立場から-
堀田　聡，中上佳寿彦，今田光彦，上田順宏，桐田忠昭
日本顎顔面インプラント学会誌．20(4)：269-279，2021．

6. 下顎骨再建手術における3次元実体モデルと歯科技工技術を併用した術前Simulationの効果
畠中利英，上田順宏，桐田忠昭
日本口腔顎顔面技工学会会誌．21(1)：21-27，2021．